ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710342 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710342; 2) Community: the network communities that were significantly associated with the response to NSC 710342; 3) Molecule: the relationships between components within communities and NSC 710342; 4) MDR: the compounds that were significantly associated with the NSC 710342.

NSC Compound Enrichment Correlation
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0162638908166157 0.51535179
NSC 630608 Null 0.0162638908166157 0.56938042
NSC 637828 Spiro[5H-dibenzo[a,d]cycloheptene-5,2'(3'H)-furan]-5'-one, 4',5'-dihydro-4'-methylene- 0.0162638908166157 0.44284742
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0162638908166157 0.41571679
NSC 641228 4-(2-fluorophenyl)-2,4-dioxo-3-(3-oxo-1,3-dihydroisobenzofuran-1-yl)-N-o-tolylbutanamide 0.0162638908166157 0.056431984
NSC 645317 Sanguilutine pseudobase 0.0162638908166157 0.57437625
NSC 657822 (1R)-3,3-Dibromocamphor 0.0162638908166157 0.44329603
NSC 664558 Null 0.0162638908166157 0.076399033
NSC 696867 1H-1,4,7-Triazonine-1-acetic acid, 4-[(dihydroxyphosphoryl)methyl]-octahydro- 0.0162638908166157 0.19786829
NSC 701748 Null 0.0162638908166157 0.40395744
Total:89  Current:37    [First] [Prev] [Next] [Last]